Diseases & Disorders
(G70Z)
990 on File
AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY
Financial strength (30%)
67/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$16.6M
Total Revenue
$17.5M
Total Expenses
$31.6M
Net Assets
55
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
69.3%
Fundraising Efficiency
858.9%
Operating Reserve
21.74x
Liability-to-Asset
28.4%
Revenue Diversification
67.3%
Executive Compensation
$1.3M
Compared with Peers
FY 2025
Compared with 105 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
69.3% | 85.4% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
26.9% | 11.1% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
3.8% | 1.0% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
858.9% | 368.9% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
21.7 mo | 10.0 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
28.4% | 23.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
67.3% | 92.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-4.0% | 7.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
7.9% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-5.2% | 3.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $16.6M | $17.5M | $31.6M | 69.3% | 55 |
| 2024 | $17.3M | $16.2M | $29.5M | 68.5% | 55 |
| 2023 | $16.9M | $16.1M | $27.0M | 67.8% | 60 |
| 2022 | $18.2M | $15.0M | $24.4M | 66.2% | 60 |
| 2021 | $15.2M | $13.5M | N/A | — | 56 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.